ClariTrial | Search Clinical Trials

Explore/infectious disease antibiotic antiviral

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

20 results for “infectious disease antibiotic antiviral” · Recruiting

Page 1 of 2

Recruiting

Assessing Antiviral Treatments in Early Symptomatic RSV

Phase 2Respiratory Syncytial VirusRespiratory Syncytial Virus, Human

RibavirinMolnupiravirFavipiravir

University of Oxford1,000 participants2 sites · Laos, ThailandCompletes Jan 2027

Compare CT.gov Full analysis →

Recruiting

Modulation of Periapical Inflammation Following Nano-sized Intracanal Medication. A Randomized Controlled Clinical Trial

N/APost-operative PainPeriapical Inflammation

Nanochitosan pasteNano-calcium hydroxide pasteCalcium hydroxide paste

Al-Azhar University63 participants1 site · EgyptCompletes Jan 2027

Compare CT.gov Full analysis →

Recruiting

Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease

N/ACrohn DiseaseStricture; BowelIntestinal Stricture

Ustekinumab

Second Affiliated Hospital, Zhejiang University, School of Medicine239 participants8 sites · ChinaCompletes Aug 2027

Compare CT.gov Full analysis →

Recruiting

Safety, Pharmacokinetics, and Antiviral Activity of Remdesivir (VEKLURY®) in Hospitalized Children With RSV

Phase 2Respiratory Syncytial Virus (RSV)

Remdesivir

PENTA Foundation120 participants8 sites · ThailandCompletes Jun 2026

Compare CT.gov Full analysis →

Recruiting

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

Phase 3BK ViremiaKidney Transplant InfectionKidney Transplant Failure and Rejection

Immunosuppression reduction/modification + intravenous immunoglobulinImmunosuppression reduction/modification

The University of Queensland280 participants13 sites · AustraliaCompletes Aug 2027

Compare CT.gov Full analysis →

Recruiting

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

Phase 3COVID-19 SARS-CoV-2 Infection

ibuzatrelvirplacebo

Pfizer2,330 participants253 sites · United States, Argentina, BelgiumCompletes Oct 2027

Compare CT.gov Full analysis →

Recruiting

Comprehensive HIV and Harm Prevention Via Telehealth

N/AHIV Infections

Comprehensive Tele-harm ReductionOff-site Linkage to HIV Prevention

University of Miami350 participants2 sites · United StatesCompletes Mar 2028

Compare CT.gov Full analysis →

Recruiting

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Phase 3Community-acquired Pneumonia, Influenza, COVID-19

CeftriaxoneMoxifloxacin or LevofloxacinPiperacillin-tazobactam+59 more

UMC Utrecht20,000 participants408 sites · United States, Australia, BelgiumCompletes Feb 2026

Compare CT.gov Full analysis →

Recruiting

CMV CTLs in Neonates With CMV Infection

Phase 2Congenital Cytomegaloviral (CMV) Disease

CMV Cytotoxic T-LymphocytesAnti-viral Therapy

New York Medical College23 participants4 sites · United StatesCompletes Oct 2027

Compare CT.gov Full analysis →

Recruiting

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Qifangfeixian Granules in the Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)

Phase 2Phase 3Interstitial Lung DiseaseQifangfeixian Granules

Qifangfeixian granulesPlacebo

Huilan Zhang124 participants1 site · ChinaCompletes May 2027

Compare CT.gov Full analysis →

Recruiting

A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

Phase 3Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

Gamunex-C, 10% Injectable Solution

Grifols Biologicals, LLC49 participants5 sites · United StatesCompletes Aug 2028

Compare CT.gov Full analysis →

Recruiting

CRP and Patient Information Leaflets to Optimise Antibiotic Treatments for Adults With Respiratory Tract Infections in Primary Care in Kyrgyzstan

N/ARespiratory Tract Infection BacterialRespiratory Tract Infection ViralAMR

The C-reactive protein point-of-care test (CRP-POCT)Patient information leaflets

Copenhagen University Hospital, Rigshospitalet1,050 participants2 sites · KyrgyzstanCompletes Mar 2026

Compare CT.gov Full analysis →

Recruiting

Efficacy of Baloxavir Against Influenza in Hospitalized Patients: The INFLUENT Study (INpatients inFLUENza Treatment)

Phase 3Influenza Disease; Flu

Baloxavir MarboxilPlacebo

Dre Pauline Vetter484 participants1 site · SwitzerlandCompletes Apr 2027

Compare CT.gov Full analysis →

Recruiting

TREATment of Lower Respiratory Tract Infection in Selected Hospitals in Southern Sri Lanka (TREAT-SL): a Stepped-Wedge Cluster Randomized Trial

N/ALower Resp Tract Infection

electronic clinical decision support tool (eCDST) diagnostic plan

Duke University765 participants3 sites · Sri LankaCompletes Mar 2027

Compare CT.gov Full analysis →

Recruiting

Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, "SIDERALE"

N/AObesityType2diabetesLipodystrophy

Mediterranean dietMelatonin supplementation

Federico II University100 participants4 sites · ItalyCompletes Oct 2025

Compare CT.gov Full analysis →

1–15 of 20

Explore/infectious disease antibiotic antiviral

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

20 results for “infectious disease antibiotic antiviral” · Recruiting

Page 1 of 2

Recruiting

Assessing Antiviral Treatments in Early Symptomatic RSV

Phase 2Respiratory Syncytial VirusRespiratory Syncytial Virus, Human

RibavirinMolnupiravirFavipiravir

University of Oxford1,000 participants2 sites · Laos, ThailandCompletes Jan 2027

Compare CT.gov Full analysis →

Recruiting

Modulation of Periapical Inflammation Following Nano-sized Intracanal Medication. A Randomized Controlled Clinical Trial

N/APost-operative PainPeriapical Inflammation

Nanochitosan pasteNano-calcium hydroxide pasteCalcium hydroxide paste

Al-Azhar University63 participants1 site · EgyptCompletes Jan 2027

Compare CT.gov Full analysis →

Recruiting

Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease

N/ACrohn DiseaseStricture; BowelIntestinal Stricture

Ustekinumab

Second Affiliated Hospital, Zhejiang University, School of Medicine239 participants8 sites · ChinaCompletes Aug 2027

Compare CT.gov Full analysis →

Recruiting

Safety, Pharmacokinetics, and Antiviral Activity of Remdesivir (VEKLURY®) in Hospitalized Children With RSV

Phase 2Respiratory Syncytial Virus (RSV)

Remdesivir

PENTA Foundation120 participants8 sites · ThailandCompletes Jun 2026

Compare CT.gov Full analysis →

Recruiting

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

Phase 3BK ViremiaKidney Transplant InfectionKidney Transplant Failure and Rejection

Immunosuppression reduction/modification + intravenous immunoglobulinImmunosuppression reduction/modification

The University of Queensland280 participants13 sites · AustraliaCompletes Aug 2027

Compare CT.gov Full analysis →

Recruiting

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

Phase 3COVID-19 SARS-CoV-2 Infection

ibuzatrelvirplacebo

Pfizer2,330 participants253 sites · United States, Argentina, BelgiumCompletes Oct 2027

Compare CT.gov Full analysis →

Recruiting

Comprehensive HIV and Harm Prevention Via Telehealth

N/AHIV Infections

Comprehensive Tele-harm ReductionOff-site Linkage to HIV Prevention

University of Miami350 participants2 sites · United StatesCompletes Mar 2028

Compare CT.gov Full analysis →

Recruiting

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Phase 3Community-acquired Pneumonia, Influenza, COVID-19

CeftriaxoneMoxifloxacin or LevofloxacinPiperacillin-tazobactam+59 more

UMC Utrecht20,000 participants408 sites · United States, Australia, BelgiumCompletes Feb 2026

Compare CT.gov Full analysis →

Recruiting

CMV CTLs in Neonates With CMV Infection

Phase 2Congenital Cytomegaloviral (CMV) Disease

CMV Cytotoxic T-LymphocytesAnti-viral Therapy

New York Medical College23 participants4 sites · United StatesCompletes Oct 2027

Compare CT.gov Full analysis →

Recruiting

Phase 2Phase 3Interstitial Lung DiseaseQifangfeixian Granules

Qifangfeixian granulesPlacebo

Huilan Zhang124 participants1 site · ChinaCompletes May 2027

Compare CT.gov Full analysis →

Recruiting

Phase 3Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

Gamunex-C, 10% Injectable Solution

Grifols Biologicals, LLC49 participants5 sites · United StatesCompletes Aug 2028

Compare CT.gov Full analysis →

Recruiting

CRP and Patient Information Leaflets to Optimise Antibiotic Treatments for Adults With Respiratory Tract Infections in Primary Care in Kyrgyzstan

N/ARespiratory Tract Infection BacterialRespiratory Tract Infection ViralAMR

The C-reactive protein point-of-care test (CRP-POCT)Patient information leaflets

Copenhagen University Hospital, Rigshospitalet1,050 participants2 sites · KyrgyzstanCompletes Mar 2026

Compare CT.gov Full analysis →

Recruiting

Efficacy of Baloxavir Against Influenza in Hospitalized Patients: The INFLUENT Study (INpatients inFLUENza Treatment)

Phase 3Influenza Disease; Flu

Baloxavir MarboxilPlacebo

Dre Pauline Vetter484 participants1 site · SwitzerlandCompletes Apr 2027

Compare CT.gov Full analysis →

Recruiting

TREATment of Lower Respiratory Tract Infection in Selected Hospitals in Southern Sri Lanka (TREAT-SL): a Stepped-Wedge Cluster Randomized Trial

N/ALower Resp Tract Infection

electronic clinical decision support tool (eCDST) diagnostic plan

Duke University765 participants3 sites · Sri LankaCompletes Mar 2027

Compare CT.gov Full analysis →

Recruiting

Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, "SIDERALE"

N/AObesityType2diabetesLipodystrophy

Mediterranean dietMelatonin supplementation

Federico II University100 participants4 sites · ItalyCompletes Oct 2025

Compare CT.gov Full analysis →

1–15 of 20